Vaccines will Drive India's Biopharma Market to $5.7bn by 2013 Says New Report

PRZOOM - /newswire/ -
London, United Kingdom, 2008/09/15 - Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report providing an overview of the biggest sector of the Indian biotechnology market, biopharma.

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!

The report “Booming Biotech Market in India” shows that biopharma made up for around 70% of the cumulative revenue in fiscal 2008 and registered INR 75.9 Billion (US$ 1.93 Billion) in revenue. Gaining strength from the ongoing research & development (R&D), the biopharma sector will exceed INR 224 Billion (US$ 5.7 Billion) by fiscal 2013.

According to the study, the total biopharma industry - consisting of therapeutics, vaccines, diagnostics, and other products such as statins - recorded a massive 26.9% growth in fiscal 2007 and continues to be the largest contributor to the overall biotech market in India.

The impressive performance of the Indian biopharma sector is the result of the strongly growing vaccine business, which accounted for about 50% of the total biopharma business in fiscal 2007. The vaccine business will remain dynamic in future, taking the overall biopharma market up. In addition to this, driven by a rise in chronic diseases and investments in the healthcare infrastructure, diagnostics and therapeutics business is also anticipated to have a bright future. The biopharma sector will further benefit from the fact that India is forecast to become a key biogenerics supplier to the developed world in near future.

The report is an exhaustive study of the thriving biotech market in the emerging economy, India. It provides prudent research and analysis supported by statistical facts and figures on parameters that make up the structure of the Indian biotech market. It describes the market landscape and gives comprehensive information on market size, structure, key segments, domestic consumption, exports, investment, and market share of key players.

“Booming Biotech Market in India” is available from Report Buyer. For more information, see website.

Report Buyer product ID: RCS00434

About Report Buyer
Report Buyer (reportbuyer.com) is a UK-based independent online store supplying business information. The website now carries over 85,000 business information products, including market reports, studies, books and events. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. A regularly updated blog provides information on the latest market trends.

PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Report Buyer Ltd securities in any jurisdiction including any other companies listed or named in this release.